<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Neonatal necrotizing enterocolitis: Pathology and pathogenesis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Neonatal necrotizing enterocolitis: Pathology and pathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Neonatal necrotizing enterocolitis: Pathology and pathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jae H Kim, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven A Abrams, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 10, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Necrotizing enterocolitis (NEC) is one of the most common gastrointestinal emergencies in the newborn infant. It is a disorder characterized by ischemic necrosis of the intestinal mucosa, which is associated with severe inflammation, invasion of enteric gas forming organisms, and dissection of gas into the bowel wall and portal venous system [<a href="#rid1">1</a>]. Although early recognition and aggressive treatment of this disorder has improved clinical outcomes, NEC accounts for substantial long-term morbidity in survivors of neonatal intensive care, particularly in preterm very low birth weight (VLBW) infants (BW below 1500 g). </p><p>Although first described in 1965, the etiology and pathogenesis of NEC remains uncertain [<a href="#rid1">1</a>]. The pathology and pathogenesis of NEC are reviewed here. The clinical features, management, and prevention of this disorder are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5019.html" rel="external">"Neonatal necrotizing enterocolitis: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5006.html" rel="external">"Neonatal necrotizing enterocolitis: Management and prognosis"</a> and  <a class="medical medical_review" href="/z/d/html/5040.html" rel="external">"Neonatal necrotizing enterocolitis: Prevention"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>The pathology of NEC is primarily due to changes from severe intestinal inflammation and infarction [<a href="#rid2">2</a>]. The specific findings range from mucosal injury to full-thickness bowel necrosis and perforation  (<a class="graphic graphic_picture graphicRef130376" href="/z/d/graphic/130376.html" rel="external">picture 1</a>). The terminal ileum and colon are involved in the majority of cases, although the entire gastrointestinal (GI) tract is affected in severe cases.</p><p>On gross examination, the bowel appears distended and hemorrhagic  (<a class="graphic graphic_picture graphicRef130376" href="/z/d/graphic/130376.html" rel="external">picture 1</a>). Subserosal collections of gas, seen as pneumatosis intestinalis on abdominal radiographs, occasionally are present along the mesenteric border  (<a class="graphic graphic_figure graphicRef117369" href="/z/d/graphic/117369.html" rel="external">figure 1</a>). Gangrenous necrosis occurs on the antimesenteric border, and perforation may be present. As the gut heals, thickening of the bowel walls, fibrinous adhesions, and areas of stenosis appear.</p><p>The major histologic findings in NEC are mucosal edema, hemorrhage, and transmural bland necrosis  (<a class="graphic graphic_figure graphicRef117369" href="/z/d/graphic/117369.html" rel="external">figure 1</a>). Other findings include acute inflammation, secondary bacterial infiltration, and collections of gas. Vascular thrombi are rare.</p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS: PRETERM INFANT</span></p><p class="headingAnchor" id="H4"><span class="h2">Overview: Multifactorial process</span><span class="headingEndMark"> — </span>The pathogenesis of NEC remains unknown. For the 90 percent of cases that occur in preterm infants, available evidence supports a multiple-factorial mechanism that requires the concurrent presence of an immature intestinal tract and immune system (increased susceptibility), triggers that lead to dysbiosis (disruption of the normal intestinal bacterial flora [microbiome], resulting in increased growth of potentially pathogenic bacteria), and an exaggerated inflammatory host response with release of cytokines and chemokines  (<a class="graphic graphic_figure graphicRef117028" href="/z/d/graphic/117028.html" rel="external">figure 2</a>): </p><p class="bulletIndent1"><span class="glyph">●</span>Increased susceptibility due to intestinal and immunologic immaturity</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Trigger event or factors contribute to changes in the microbiome of the intestinal tract (microbial dysbiosis and/or primary infection) and disruption of the intestinal mucosal barrier and microvasculature. These include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Non-human milk feedings and rarely components in human milk may trigger a sensitivity or allergic response (eg, food protein-induced enterocolitis syndrome, milk protein allergy). (See  <a class="medical medical_review" href="/z/d/html/16528.html" rel="external">"Food protein-induced enterocolitis syndrome (FPIES)"</a> and  <a class="medical medical_review" href="/z/d/html/2386.html" rel="external">"Milk allergy: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Medications that cause intestinal mucosal injury or enhance microbial overgrowth (eg, antibiotics)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Circulatory instability</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anemia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyper-inflammatory response mediated by toll-like receptor-4 (TLR-4) innate immunity to trigger events within the intestinal tract</p><p></p><p class="headingAnchor" id="H2201971335"><span class="h2">Susceptibility: Immunologic and intestinal immaturity</span><span class="headingEndMark"> — </span>Preterm infants are susceptible to the development of NEC because immunologic and intestinal immaturity results in a susceptible host for potential mucosal injury. The risk of NEC increases with decreasing gestational age (GA) and is greatest in the extremely preterm infant (GA &lt;28 weeks) [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/5019.html" rel="external">"Neonatal necrotizing enterocolitis: Clinical features and diagnosis", section on 'Epidemiology'</a>.)</p><p>Mucosal defense in the gut is mediated by several interrelated components, some of which provide a physical barrier and others a biochemical and immunologic barrier [<a href="#rid4">4-7</a>]. The impairment of the mucosal barrier allows bacteria to gain access to deeper tissues resulting in inflammation. (See <a class="local">'Host immune and inflammatory response'</a> below.)</p><p>Increased susceptibility, which predisposes the preterm infant to NEC, is due the following  (<a class="graphic graphic_figure graphicRef68015" href="/z/d/graphic/68015.html" rel="external">figure 3</a>) [<a href="#rid4">4,7,8</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Immature mucosal physical barrier with increased permeability and bacterial penetration into the intestinal wall (translocation) compared with term infants. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The intestinal mucin barrier is not fully developed in the very preterm infant. Mucin, which is secreted by the goblet cells, hampers bacterial epithelial binding and enhances bacterial removal [<a href="#rid4">4,7</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>There is increased permeability most likely due to immaturity of the composition and function of the tight junctions [<a href="#rid9">9</a>]. Tight junctions between epithelial cells maintain the semipermeable property of the intestinal tract.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immature immunity and biochemical protection with diminished concentrations of secretory immunoglobulin A (IgA; the major intestinal immunoprotective antibody), mucosal enzymes (eg, pepsin and proteases), and other protective agents (eg, defensins, lactoferrin), and increased gastric pH, which promotes bacterial overgrowth [<a href="#rid4">4,7,9,10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immature gut motility and function. Preterm infants have dysfunctional gastric emptying and decreased bowel motility. This results in delayed transit time, which increases bacterial proliferation and overgrowth [<a href="#rid11">11</a>].</p><p></p><p class="headingAnchor" id="H3839324237"><span class="h2">Potential triggers and risk factors</span><span class="headingEndMark"> — </span>It is postulated that trigger events and environmental factors initiate intestinal injury in a vulnerable host (preterm infant), which prompts a hyper-inflammatory response that cannot be well-regulated due to an immature immune system.</p><p>There is good evidence that microbial dysbiosis and non-human milk feeding are risk factors for NEC [<a href="#rid11">11-13</a>]. In addition, more limited evidence suggest that hyperosmolar agents and histamine type 2 (H2) receptor blockers that increase intestinal pH are also environmental risk factors.</p><p>The evidence is also unclear whether there is an association between NEC and primary infection, circulatory instability, or anemia and red blood cell (RBC) transfusion.  </p><p class="headingAnchor" id="H2517643591"><span class="h3">Microbial dysbiosis</span><span class="headingEndMark"> — </span>Increasingly, there is evidence that disruption of commensal bacterial colonization that potentially include pathogenic bacteria (microbial dysbiosis) plays a key role in the development of NEC [<a href="#rid8">8,14-19</a>]. Interestingly, NEC does not occur in utero despite evidence that supports the presence of microbes in meconium, which may indicate that certain pathogenic bacteria are required for the development of NEC. NEC rarely occurs without the presence of feeding, which stimulates the growth of and changes in the intestinal microbiome. The type of feeding (human milk versus bovine-based formula) can have positive or negative effects on the microbiome and subsequent development of NEC. (See <a class="local">'Milk feeding'</a> below and  <a class="medical medical_review" href="/z/d/html/5040.html" rel="external">"Neonatal necrotizing enterocolitis: Prevention", section on 'Human milk feeding'</a>.)</p><p>Commensal bacteria play a symbiotic role with the intestine through toll-like receptors by regulating the expression of genes involved in intestinal maturation, function (eg, barrier, digestion, angiogenesis, production of IgA), and protection against more pathologic organisms [<a href="#rid8">8,10,14,20,21</a>]. Longitudinal stool colonization studies have shown that microbial dysbiosis in the absence of primary infection results in mucosal injury that affects intestinal maturation and increases intestinal permeability. The increased intestinal permeability contributes to greater bacterial translocation from the intestinal lumen into the intestinal tissue, leading to an inflammatory response with activation of cytokines, apoptosis, and necrosis [<a href="#rid15">15,17,18</a>]. Additionally, specific bacterial products (postbiotics) such as formate have been associated with NEC through metagenomic and targeted metabolomic analyses [<a href="#rid22">22</a>]. (See <a class="local">'Host immune and inflammatory response'</a> below.) </p><p>Growth factors, such as epidermal growth factor (EGF), are important in intestinal development and preservation of gut barrier function. Animal models and studies in humans suggest a protective role for EGF in the pathogenesis of NEC, including a modulating role in the toll-like receptor 4 pathway of inflammation [<a href="#rid23">23</a>]. </p><p>It remains uncertain whether early exposure to antibiotic therapy contributes to microbial dysbiosis and risk of NEC. Some studies found that early and prolonged (ie, ≥5 days) antibiotic administration were associated with an increased risk of NEC [<a href="#rid24">24-29</a>]; while other studies reported a lower risk of NEC among neonates who received early antibiotic therapy [<a href="#rid30">30</a>]. </p><p>The use of probiotic therapy has been proposed to alter the microbial dysbiosis and promote commensal intestinal bacteria, which may inhibit inflammatory pathways and decrease the risk of developing NEC. This is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5040.html" rel="external">"Neonatal necrotizing enterocolitis: Prevention", section on 'Probiotics'</a>.)</p><p class="headingAnchor" id="H6"><span class="h3">Milk feeding</span><span class="headingEndMark"> — </span>More than 90 percent of infants who develop NEC have received enteral feeding [<a href="#rid31">31</a>]. Although both human milk and bovine-based infant formulas can serve as substrates for bacterial proliferation in the gut, the risk of NEC is greater with infant formula. Newborns, especially preterm infants, have not developed the ability to completely digest and absorb nutrients. As a result, bacterial fermentation of milk products of incompletely digested carbohydrates and lipids (eg, reducing substances, organic acids, short chain fatty acids, carbon dioxide, and hydrogen gas) in the intestine of preterm infants may cause mucosal injury [<a href="#rid32">32</a>]. The immature dysmotility in preterm infants can exacerbate this process by delaying transit time. Supportive data was provided by a study using an animal model that demonstrated a mixture of casein, organic acids, and low pH led to mucosal injury with infiltration of cellular elements and vasoactive compounds [<a href="#rid33">33</a>].</p><p>Indirect evidence supporting feeding as a risk factor for NEC is provided by the observation that there is an inverse relationship between timing of NEC and GA. For example, the median age at onset in infants with a GA of less than 26 weeks was 23 days compared with a median age of 11 days for more mature infants with a GA of greater than 31 weeks [<a href="#rid34">34</a>]. There are two main possible explanations for this finding. The first proposes that because most preterm infants take longer to begin enteral feeding, it takes them longer to reach a critical amount of feeding mass needed for the development of NEC. Another possibility is that there are changes with development that make an infant more prone to intestinal inflammation or immune dysregulation as they mature.</p><p>Although NEC is associated with enteral feeds, it does not appear that feeding-related factors are important in the development of NEC. (See  <a class="medical medical_review" href="/z/d/html/5040.html" rel="external">"Neonatal necrotizing enterocolitis: Prevention", section on 'Standardized feeding protocol'</a>.)</p><p class="headingAnchor" id="H7"><span class="h4">Human milk</span><span class="headingEndMark"> — </span>Human milk, compared with formula, is more protective against NEC in preterm infants because it contains components (not found in formula) that reduce inflammation while not introducing foreign antigens in the GI tract  (<a class="graphic graphic_figure graphicRef90314" href="/z/d/graphic/90314.html" rel="external">figure 4</a>). These protective factors within human milk include oligosaccharides, lactoferrin, lysozyme, platelet activating factor acetylhydrolase, secretory IgA, cytokines (interleukin [IL]-10, IL-11), epidermal growth factors (EGFs) [<a href="#rid35">35</a>], nucleotides, glutamine, and antioxidants such as <a class="drug drug_pediatric" data-topicid="12884" href="/z/d/drug information/12884.html" rel="external">vitamin E</a>, carotene, and glutathione. In addition, human milk microbes (prebiotic) in combination with human milk oligosaccharides (prebiotic) appear to synergically influence the development of the neonatal intestinal microbiome [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/z/d/html/5040.html" rel="external">"Neonatal necrotizing enterocolitis: Prevention", section on 'Human milk feeding'</a>.)</p><p>Human milk feeding is also more likely associated with growth of nonpathogenic bacteria (commensal bacteria) compared to formula [<a href="#rid37">37</a>]. The mucus coat of the intestine is less affected by human milk, and growth factors within human milk (ie, EGFs) repair disruptions in this layer. Human milk improves intestinal motility, which avoids milk stasis and decreases intestinal permeability. Human milk also stimulates the mucosal defense system so that local immune activation is thwarted. </p><p class="headingAnchor" id="H2437710020"><span class="h3">Medications</span></p><p class="headingAnchor" id="H1485592623"><span class="h4">Hyperosmolar agents</span><span class="headingEndMark"> — </span>The administration of hyperosmolar medications and/or formulas can cause mucosal injury and may result in NEC [<a href="#rid38">38-40</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Oral medications such as multivitamins or <a class="drug drug_pediatric" data-topicid="12698" href="/z/d/drug information/12698.html" rel="external">phenobarbital</a> contain hypertonic additives that might irritate the intestinal mucosa.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Instillation of hyperosmolar contrast agents into the bowel for diagnostic radiographic studies can cause mucosal injury because of fluid shifts, bowel distention, and ischemia. Isotonic contrast agents should be used to avoid this complication.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperosmolar formulas, which are concentrated above recommended strengths or containing multiple additives, should be avoided in the first few weeks after birth and preferably when feeds have reached full volume.</p><p></p><p class="headingAnchor" id="H1213468895"><span class="h4">Agents that reduce gastric acidity</span><span class="headingEndMark"> — </span>Histamine type 2 (H2) receptor antagonists, such as <a class="drug drug_pediatric" data-topicid="13156" href="/z/d/drug information/13156.html" rel="external">cimetidine</a>, <a class="drug drug_pediatric" data-topicid="12759" href="/z/d/drug information/12759.html" rel="external">ranitidine</a>, and <a class="drug drug_pediatric" data-topicid="13295" href="/z/d/drug information/13295.html" rel="external">famotidine</a>, are associated with higher rates of NEC. This was illustrated in a report from the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network [<a href="#rid41">41</a>]. In this study of 11,072 preterm infants (birth weight [BW] 401 to 1500 g) from 1998 to 2001, the incidence of NEC was 7.1 percent. Infants with NEC compared with matched controls were more likely to have received H2 antagonists (odds ratio [OR] 1.71, 95% CI 1.34-2.19). A possible explanation for this finding is that gastric acidity, which may reduce the risk of NEC by inhibiting bacterial growth [<a href="#rid42">42</a>], was lowered by the use of H2 antagonists. A subsequent study reconfirmed the negative effects of acid blockade with increased infection rates in infants on this class of drug [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H2023741536"><span class="h3">Unproven risk factors</span></p><p class="headingAnchor" id="H9"><span class="h4">Primary infection</span><span class="headingEndMark"> — </span>Less frequently, NEC has been reported to be associated with primary invasions of the gut by pathogenic enteric bacteria. In these small case series, bacterial organisms usually found in the distal GI tract have been recovered from the blood and peritoneal cavities of patients with NEC. These organisms include <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, <em>Pseudomonas</em>, and <em>Clostridioides difficile </em>[<a href="#rid44">44-46</a>].</p><p>In addition to these bacteria, viral and fungal pathogens have been isolated in some sporadic cases of NEC and in epidemic outbreaks [<a href="#rid47">47-49</a>]. Virus particles have been isolated from the stools of infants with NEC and their caregivers, including their mothers, the midwives, and the nursery nursing staff. Injury caused by infectious agents may be aggravated by inflammatory mediators. (See <a class="local">'Host immune and inflammatory response'</a> below.)</p><p>The use of molecular techniques may prove to be a useful tool in evaluating the role of infection in the pathogenesis of NEC. In a small prospective study, stool samples from 12 infants less than 34 weeks gestation who were admitted to the neonatal intensive care unit (NICU) were analyzed using polymerase chain reaction (PCR) and gel electrophoresis [<a href="#rid50">50</a>]. <em>Clostridium perfringens</em> was recognized during the first two weeks of life in the three infants who later developed NEC, but not in the nine infants who did not.</p><p class="headingAnchor" id="H11"><span class="h4">Circulatory instability</span><span class="headingEndMark"> — </span>It has long been proposed that ischemic insult to the GI tract is a key contributor to NEC. However, most preterm infants with NEC have not had an obvious perinatal hypoxic-ischemic event [<a href="#rid51">51</a>]. Circulatory events have been implicated by observational case series in term infants, including patients with congenital heart disease [<a href="#rid52">52,53</a>], polycythemia [<a href="#rid54">54,55</a>], and RBC [<a href="#rid56">56-58</a>] and exchange transfusions [<a href="#rid59">59</a>]. A diminished blood supply to the gut may contribute to the pathogenesis of NEC in infants exposed to cocaine [<a href="#rid60">60</a>]. In addition, there are small studies that have reported insufficient intestinal perfusion either antenatally or postnatally [<a href="#rid52">52,61</a>].</p><p>These observations are inadequate to conclusively show that ischemia is a contributing factor in the development of NEC in preterm infants. Nevertheless, it still is thought that a subtle reduction in blood flow and subsequent reperfusion occurring in response to hypoxia may contribute to bowel injury.</p><p class="headingAnchor" id="H31669350"><span class="h4">Anemia and red blood cell transfusion</span><span class="headingEndMark"> — </span>Although data suggest an association between the development of NEC, anemia, and red blood cell (RBC) transfusion, the nature of the association remains unclear. Observational studies and a systematic review noted an association between red blood cell (RBC) transfusions and increased risk of NEC [<a href="#rid56">56-58,62-66</a>]. In contrast, a large multicenter observational cohort study reported that severe anemia and not RBC transfusion was associated with NEC [<a href="#rid67">67</a>]. </p><p>In this study of 598 very low birth weight (VLBW) infants (BW ≤1500 g), multivariable analysis showed no difference in the rate of NEC (defined as Bell stage 2 or greater) between infants exposed to transfusions within a week of developing NEC versus those who were not exposed. In contrast, the risk of NEC was increased in infants with severe anemia (hemoglobin level ≤8 g/dL) within a week of developing NEC compared with those who did not have severe anemia (adjusted cause-specific hazard ratio [HR] 5.99, 95% CI 2-18). Unlike previous reports, this study adjusted for confounding factors including BW, center, breastfeeding for less than 10 days, illness severity, and duration of antibiotic therapy.</p><p>These results suggest that clinically-significant anemia is associated with an increased risk for NEC, and that RBC transfusion is either a surrogate marker for anemia or potentiates bowel injury when severe anemia is present. However, the observational nature of this study prohibits the ability to determine causation between NEC and significant anemia, and also does not account for all potential confounding factors (eg, long-term breastfeeding beyond 10 days). A subsequent review of the literature reported that the pooled data from the included published studies failed to demonstrate an association between NEC and RBC transfusion [<a href="#rid68">68</a>]. Within the same review, a pooled analysis of three trials examining the relationship between NEC and different transfusion thresholds reported less frequent NEC among infants in the liberal versus restrictive transfusion groups. However, the overall quality of the evidence was rated as low to very low because of inconsistency among the studies, the lack of a consistent definition, and heterogeneity amongst the patient groups.</p><p>In another study, blood transfusions were associated with increases in intestinal fatty acid binding protein and may suggest a possible mechanism for transfusion related intestinal injury [<a href="#rid69">69</a>]. </p><p>Management of anemia and RBC transfusion in preterm neonates at risk for NEC is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5040.html" rel="external">"Neonatal necrotizing enterocolitis: Prevention", section on 'Prevent severe anemia/Decrease exposure to RBC transfusion'</a>.) </p><p>The indications and administration of red blood cell transfusions in the newborn are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/5041.html" rel="external">"Red blood cell (RBC) transfusions in the neonate"</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Host immune and inflammatory response</span><span class="headingEndMark"> — </span>Increasingly, data show that an exaggerated inflammatory immune response initiated by the innate immune system to environmental triggers is an important pathogenic component in the development of NEC. In very preterm infants (GA &lt;32 weeks), there is a deficiency in antibody-mediated immunity, as immunoglobulins do not cross the placenta until the second trimester with a linear increase in levels as pregnancy progresses [<a href="#rid7">7,70</a>]. As a result, the innate immune system is the primary immunologic protective system in very preterm infants. Toll-like receptors (TLR) found on the apical border of intestinal epithelial cells are a major component of innate immunity, including TLR-4, which binds to lipopolysaccharide (LPS, a component of gram-negative bacteria). In patients with NEC, exaggerated and uncontrolled TLR signaling induced by infectious agents, particularly gram-negative bacteria and mucosal irritants, results in marked inflammation leading to the release of cytokines and chemokines. These inflammatory mediators further aggravate mucosal injury, increase vascular permeability, and attract inflammatory cells, resulting in apoptosis and cellular necrosis of the bowel [<a href="#rid10">10,71</a>]. Data have shown that levels of cytokines are increased in preterm infants with NEC and correlate with the severity of the NEC disease and include tumor necrosis factor (TNF), interleukins (IL-1, IL-6, IL-8, IL-10, IL-12, and IL-18), and platelet activating factor (PAF). These inflammatory mediators increase vascular permeability and attract inflammatory cells [<a href="#rid10">10,72-75</a>].</p><p>This cascade of cellular events may be mediated at least in part by PAF, which is synthesized by many cell types, including macrophages, neutrophils, eosinophils, and endothelial cells [<a href="#rid76">76</a>]. In animal models, administration of PAF causes intestinal necrosis as well as systemic hypotension, capillary leakage, pulmonary hypertension, neutropenia, and thrombocytopenia [<a href="#rid76">76</a>]. In humans, plasma concentrations of PAF are higher in infants taking milk feedings, however, acetylhydrolase present in human milk breaks down PAF [<a href="#rid76">76</a>]. Plasma acetylhydrolase activity is lower in infants with NEC compared with controls and may contribute to the increased concentrations of PAF [<a href="#rid72">72</a>].</p><p class="headingAnchor" id="H633847325"><span class="h3">Chorioamnionitis</span><span class="headingEndMark"> — </span>Chorioamnionitis is an antenatal proinflammatory process involving the placenta and fetal membrane, which may play a contributing role in the pathogenesis of NEC. However, data are inconclusive whether it is a significant clinical risk factor, as illustrated by the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Meta-analysis of studies examining the relationship between NEC and chorioamnionitis confirmed by histology found no significant association between histologic-confirmed chorioamnionitis and NEC [<a href="#rid77">77</a>]. However, a subgroup analysis demonstrated an association between NEC and histologic-confirmed chorioamnionitis that included fetal involvement.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Subsequently published retrospective studies have reported conflicting results regarding the contribution of chorioamnionitis in the pathogenesis of NEC [<a href="#rid78">78,79</a>].</p><p></p><p>Further investigation is needed to determine whether there is a significant clinical role of chorioamnionitis in the pathogenesis of NEC.</p><p class="headingAnchor" id="H14"><span class="h3">Intestinal vascular resistance</span><span class="headingEndMark"> — </span>Mucosal injury and inflammation may alter the balance of endogenous vasoactive agents, which may contribute to the development of NEC with changes in the intestinal vascular resistance and microcirculation [<a href="#rid6">6,80-82</a>]. Data are limited on the roles of nitric oxide, the primary vasodilator, and endothelin-1, a potent vasoconstrictor, in the pathogenesis of NEC.</p><p class="bulletIndent1"><span class="glyph">●</span>Endothelin-1 (ET-1) – In a pathologic study of resected intestinal specimens from infants with suspected NEC, there were increased levels of ET-1 in areas that demonstrated histological findings consistent with NEC as compared with unaffected tissue from the same specimen [<a href="#rid82">82</a>]. In addition, arterioles showed increased vasoconstriction in affected compared with unaffected tissue that was reversed by an endothelin receptor antagonist.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nitric oxide (NO) – The limited data available on the role of NO are conflicting.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In one report, inducible NO synthase (iNOS) gene and protein expression were detected more often in apical enterocytes in infants undergoing surgical resection for NEC than for intestinal atresia or other noninflammatory conditions [<a href="#rid81">81</a>]. These results would suggest that increased NO may contribute to failure of gut barrier function, bacterial translocation, and direct intestinal damage.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In contrast, another study reported that although endothelial NO synthase (eNOS) was present in specimens from infants undergoing surgical resection for NEC and control patients with intestinal atresia, eNOS function was impaired, resulting in decreased NO production in arterioles from NEC specimens compared with controls [<a href="#rid83">83</a>]. Arterioles from patients with NEC failed to normally dilate in response to acetylcholine stimulation or increased arteriolar blood flow.</p><p></p><p class="headingAnchor" id="H583880645"><span class="h1">PATHOGENESIS: TERM INFANT</span><span class="headingEndMark"> — </span>NEC in term infants or infants with birth weight (BW) &gt;2500 g is generally associated with predisposing or underlying condition, such as congenital heart disease, primary gastrointestinal defects perinatal asphyxia, polycythemia, sepsis, hypotension, endocrine disorders, and respiratory disease [<a href="#rid84">84-92</a>]. In addition, there is evidence that infants with neonatal abstinence syndrome may be at risk for NEC [<a href="#rid85">85</a>]. </p><p>Although the underlying mechanism for NEC in term infants is unknown, it is postulated impaired mesenteric oxygenation due to poor perfusion or cyanosis is a major predisposing factor that contribute to the development of NEC, along with non-human milk feeding [<a href="#rid52">52,85,89,91</a>]. As a result, the pathogenesis of NEC in term infants likely differs from the process that occurs in preterm infants. </p><p class="headingAnchor" id="H100577829"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/83039.html" rel="external">"Patient education: Newborn necrotizing enterocolitis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H15"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathology of necrotizing enterocolitis (NEC)</strong> – NEC is the most common gastrointestinal emergency in the newborn infant. It is a disorder manifested by ischemic necrosis of the intestinal mucosa associated with intense transmural inflammation, invasion of enteric gas-forming organisms, and dissection of gas into the muscularis and portal venous system. The pathologic findings of NEC vary depending upon the progression of the disease. In general, the bowel appears distended and hemorrhagic on gross examination  (<a class="graphic graphic_picture graphicRef130376" href="/z/d/graphic/130376.html" rel="external">picture 1</a>). The major histologic findings include mucosal edema, hemorrhage, and transmural bland necrosis  (<a class="graphic graphic_figure graphicRef117369" href="/z/d/graphic/117369.html" rel="external">figure 1</a>). (See <a class="local">'Pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis in preterm infants</strong> – NEC occurs primarily in preterm infants. Although the pathogenesis remains unknown, it is most likely due to a multifactorial process that requires the concurrent presence of a susceptible host, environmental triggers that lead to microbial dysbiosis (disruption of commensal bacterial colonization with pathogenetic bacterial overgrowth), and mucosal injury and an exaggerated inflammatory host response. (See <a class="local">'Overview: Multifactorial process'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Susceptibility</strong> – The risk of NEC increases with decreasing gestational age and is greatest in extremely preterm infants (gestational age [GA] &lt;28 weeks) due to the immunologic and intestinal immaturity. Impairment of the physical, biochemical, and immunologic barriers decreases host resistance to microbial dysbiosis and mucosal injury, and predisposes the preterm infant to NEC. (See <a class="local">'Susceptibility: Immunologic and intestinal immaturity'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Risk factors and triggers</strong> – Risk factors for NEC include prolonged exposure to antibiotics, non-human milk feeding, and administration of hyperosmolar agents or medications that reduce gastric acidity. These factors result in microbial dysbiosis and an increased likelihood of mucosal injury triggering a hyper-inflammatory response. (See <a class="local">'Microbial dysbiosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Host inflammatory response</strong> – An exaggerated and uncontrolled increase in toll-like receptor (TLR, a component of the innate immune system) signaling induced by infectious agents and mucosal irritants results in marked inflammation due to the release of cytokines and chemokines. These inflammatory mediators further aggravate mucosal injury, increase vascular permeability and attract inflammatory cells, resulting in apoptosis and tissue necrosis (the pathologic findings of NEC). (See <a class="local">'Host immune and inflammatory response'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>NEC in term infants</strong> – In term infants, NEC is generally associated with a predisposing or underlying condition, such as congenital heart disease, perinatal asphyxia, polycythemia, sepsis, hypotension, endocrine disorders, and respiratory disease. Although the underlying mechanism is unknown, it is postulated that decreased oxygen delivery to the intestinal and non-human milk feeding are risk factors for NEC. (See <a class="local">'Pathogenesis: Term infant'</a> above.)</p><p></p><p class="headingAnchor" id="H3787830886"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Richard J Schanler, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364:255.</a></li><li><a class="nounderline abstract_t">Ballance WA, Dahms BB, Shenker N, Kliegman RM. Pathology of neonatal necrotizing enterocolitis: a ten-year experience. J Pediatr 1990; 117:S6.</a></li><li><a class="nounderline abstract_t">Gordon PV, Swanson JR, MacQueen BC, Christensen RD. A critical question for NEC researchers: Can we create a consensus definition of NEC that facilitates research progress? Semin Perinatol 2017; 41:7.</a></li><li><a class="nounderline abstract_t">Hodzic Z, Bolock AM, Good M. The Role of Mucosal Immunity in the Pathogenesis of Necrotizing Enterocolitis. Front Pediatr 2017; 5:40.</a></li><li><a class="nounderline abstract_t">de la Cochetiere MF, Piloquet H, des Robert C, et al. Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res 2004; 56:366.</a></li><li><a class="nounderline abstract_t">Udall JN Jr. Gastrointestinal host defense and necrotizing enterocolitis. J Pediatr 1990; 117:S33.</a></li><li><a class="nounderline abstract_t">Denning TL, Bhatia AM, Kane AF, et al. Pathogenesis of NEC: Role of the innate and adaptive immune response. Semin Perinatol 2017; 41:15.</a></li><li><a class="nounderline abstract_t">Hunter CJ, Upperman JS, Ford HR, Camerini V. Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res 2008; 63:117.</a></li><li><a class="nounderline abstract_t">Ford HR. Mechanism of nitric oxide-mediated intestinal barrier failure: insight into the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 2006; 41:294.</a></li><li><a class="nounderline abstract_t">Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006; 368:1271.</a></li><li><a class="nounderline abstract_t">Niño DF, Sodhi CP, Hackam DJ. Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol 2016; 13:590.</a></li><li><a class="nounderline abstract_t">Samuels N, van de Graaf RA, de Jonge RCJ, et al. Risk factors for necrotizing enterocolitis in neonates: a systematic review of prognostic studies. BMC Pediatr 2017; 17:105.</a></li><li><a class="nounderline abstract_t">Gephart SM, Hanson C, Wetzel CM, et al. NEC-zero recommendations from scoping review of evidence to prevent and foster timely recognition of necrotizing enterocolitis. Matern Health Neonatol Perinatol 2017; 3:23.</a></li><li><a class="nounderline abstract_t">Patel RM, Denning PW. Intestinal microbiota and its relationship with necrotizing enterocolitis. Pediatr Res 2015; 78:232.</a></li><li><a class="nounderline abstract_t">Warner BB, Deych E, Zhou Y, et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet 2016; 387:1928.</a></li><li><a class="nounderline abstract_t">Okogbule-Wonodi AC, Gross GW, Sun CC, et al. Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants. Pediatr Res 2011; 69:442.</a></li><li><a class="nounderline abstract_t">Stewart CJ, Marrs EC, Magorrian S, et al. The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection. Acta Paediatr 2012; 101:1121.</a></li><li><a class="nounderline abstract_t">Pammi M, Cope J, Tarr PI, et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome 2017; 5:31.</a></li><li><a class="nounderline abstract_t">Neu J, Pammi M. Pathogenesis of NEC: Impact of an altered intestinal microbiome. Semin Perinatol 2017; 41:29.</a></li><li><a class="nounderline abstract_t">Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291:881.</a></li><li><a class="nounderline abstract_t">Morowitz MJ, Poroyko V, Caplan M, et al. Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics 2010; 125:777.</a></li><li><a class="nounderline abstract_t">Casaburi G, Wei J, Kazi S, et al. Metabolic model of necrotizing enterocolitis in the premature newborn gut resulting from enteric dysbiosis. Front Pediatr 2022; 10:893059.</a></li><li><a class="nounderline abstract_t">Good M, Sodhi CP, Egan CE, et al. Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor. Mucosal Immunol 2015; 8:1166.</a></li><li><a class="nounderline abstract_t">Cantey JB, Pyle AK, Wozniak PS, et al. Early Antibiotic Exposure and Adverse Outcomes in Preterm, Very Low Birth Weight Infants. J Pediatr 2018; 203:62.</a></li><li><a class="nounderline abstract_t">Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011; 159:392.</a></li><li><a class="nounderline abstract_t">Greenwood C, Morrow AL, Lagomarcino AJ, et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr 2014; 165:23.</a></li><li><a class="nounderline abstract_t">Cotten CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123:58.</a></li><li><a class="nounderline abstract_t">Rina P, Zeng Y, Ying J, et al. Association of initial empirical antibiotic therapy with increased risk of necrotizing enterocolitis. Eur J Pediatr 2020; 179:1047.</a></li><li><a class="nounderline abstract_t">Vatne A, Hapnes N, Stensvold HJ, et al. Early Empirical Antibiotics and Adverse Clinical Outcomes in Infants Born Very Preterm: A Population-Based Cohort. J Pediatr 2023; 253:107.</a></li><li><a class="nounderline abstract_t">Li Y, Shen RL, Ayede AI, et al. Early Use of Antibiotics Is Associated with a Lower Incidence of Necrotizing Enterocolitis in Preterm, Very Low Birth Weight Infants: The NEOMUNE-NeoNutriNet Cohort Study. J Pediatr 2020; 227:128.</a></li><li><a class="nounderline abstract_t">Berseth CL. Feeding strategies and necrotizing enterocolitis. Curr Opin Pediatr 2005; 17:170.</a></li><li><a class="nounderline abstract_t">Sylvester KG, Kastenberg ZJ, Moss RL, et al. Acylcarnitine Profiles Reflect Metabolic Vulnerability for Necrotizing Enterocolitis in Newborns Born Premature. J Pediatr 2017; 181:80.</a></li><li><a class="nounderline abstract_t">Clark DA, Miller MJ. Intraluminal pathogenesis of necrotizing enterocolitis. J Pediatr 1990; 117:S64.</a></li><li><a class="nounderline abstract_t">Yee WH, Soraisham AS, Shah VS, et al. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics 2012; 129:e298.</a></li><li><a class="nounderline abstract_t">Caplan M. Is EGF the Holy Grail for NEC? J Pediatr 2007; 150:329.</a></li><li><a class="nounderline abstract_t">Le Doare K, Holder B, Bassett A, Pannaraj PS. Mother's Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity. Front Immunol 2018; 9:361.</a></li><li><a class="nounderline abstract_t">Savage JH, Lee-Sarwar KA, Sordillo JE, et al. Diet during Pregnancy and Infancy and the Infant Intestinal Microbiome. J Pediatr 2018; 203:47.</a></li><li><a class="nounderline abstract_t">Tuladhar R, Daftary A, Patole SK, Whitehall JS. Oral gastrografin in neonates: a note of caution. Int J Clin Pract 1999; 53:565.</a></li><li><a class="nounderline abstract_t">Sann L, Baltassat P, You JE, et al. [Role of a hypertonic theophylline solution and blood transfusion in necrotizing colitis]. Pediatrie 1985; 40:267.</a></li><li><a class="nounderline abstract_t">Book LS, Herbst JJ, Atherton SO, Jung AL. Necrotizing enterocolitis in low-birth-weight infants fed an elemental formula. J Pediatr 1975; 87:602.</a></li><li><a class="nounderline abstract_t">Guillet R, Stoll BJ, Cotten CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006; 117:e137.</a></li><li><a class="nounderline abstract_t">Carrion V, Egan EA. Prevention of neonatal necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 1990; 11:317.</a></li><li><a class="nounderline abstract_t">Manzoni P, García Sánchez R, Meyer M, et al. Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactoferrin Counteracts This Effect. J Pediatr 2018; 193:62.</a></li><li><a class="nounderline abstract_t">Uauy RD, Fanaroff AA, Korones SB, et al. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1991; 119:630.</a></li><li><a class="nounderline abstract_t">Cassir N, Benamar S, Khalil JB, et al. Clostridium butyricum Strains and Dysbiosis Linked to Necrotizing Enterocolitis in Preterm Neonates. Clin Infect Dis 2015; 61:1107.</a></li><li><a class="nounderline abstract_t">Heida FH, van Zoonen AG, Hulscher JB, et al. A Necrotizing Enterocolitis-Associated Gut Microbiota Is Present in the Meconium: Results of a Prospective Study. Clin Infect Dis 2016; 62:863.</a></li><li><a class="nounderline abstract_t">Dittmar E, Beyer P, Fischer D, et al. Necrotizing enterocolitis of the neonate with Clostridium perfringens: diagnosis, clinical course, and role of alpha toxin. Eur J Pediatr 2008; 167:891.</a></li><li><a class="nounderline abstract_t">Stuart RL, Tan K, Mahar JE, et al. An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3. Pediatr Infect Dis J 2010; 29:644.</a></li><li><a class="nounderline abstract_t">Panesso-Gómez S, Shimamura M, Conces M, et al. Detection of Cytomegalovirus in Intestinal Tissue of Infants with Necrotizing Enterocolitis or Spontaneous Intestinal Perforation. J Pediatr 2019; 214:34.</a></li><li><a class="nounderline abstract_t">Turcios-Ruiz RM, Axelrod P, St John K, et al. Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit. J Pediatr 2008; 153:339.</a></li><li><a class="nounderline abstract_t">Nowicki P. Intestinal ischemia and necrotizing enterocolitis. J Pediatr 1990; 117:S14.</a></li><li><a class="nounderline abstract_t">Carlo WF, Kimball TR, Michelfelder EC, Border WL. Persistent diastolic flow reversal in abdominal aortic Doppler-flow profiles is associated with an increased risk of necrotizing enterocolitis in term infants with congenital heart disease. Pediatrics 2007; 119:330.</a></li><li><a class="nounderline abstract_t">Fisher JG, Bairdain S, Sparks EA, et al. Serious congenital heart disease and necrotizing enterocolitis in very low birth weight neonates. J Am Coll Surg 2015; 220:1018.</a></li><li><a class="nounderline abstract_t">Hakanson DO, Oh W. Necrotizing enterocolitis and hyperviscosity in the newborn infant. J Pediatr 1977; 90:458.</a></li><li><a class="nounderline abstract_t">Nowicki PT, Oh W, Yao A, et al. Effect of polycythemia on gastrointestinal blood flow and oxygenation in piglets. Am J Physiol 1984; 247:G220.</a></li><li><a class="nounderline abstract_t">Christensen RD, Lambert DK, Henry E, et al. Is "transfusion-associated necrotizing enterocolitis" an authentic pathogenic entity? Transfusion 2010; 50:1106.</a></li><li><a class="nounderline abstract_t">Josephson CD, Wesolowski A, Bao G, et al. Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants? J Pediatr 2010; 157:972.</a></li><li><a class="nounderline abstract_t">Blau J, Calo JM, Dozor D, et al. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr 2011; 158:403.</a></li><li><a class="nounderline abstract_t">Touloukian RJ, Kadar A, Spencer RP. The gastrointestinal complications of neonatal umbilical venous exchange transfusion: a clinical and experimental study. Pediatrics 1973; 51:36.</a></li><li><a class="nounderline abstract_t">Farrar HC, Kearns GL. Cocaine: clinical pharmacology and toxicology. J Pediatr 1989; 115:665.</a></li><li><a class="nounderline abstract_t">Kamoji VM, Dorling JS, Manktelow B, et al. Antenatal umbilical Doppler abnormalities: an independent risk factor for early onset neonatal necrotizing enterocolitis in premature infants. Acta Paediatr 2008; 97:327.</a></li><li><a class="nounderline abstract_t">Christensen RD. Association between red blood cell transfusions and necrotizing enterocolitis. J Pediatr 2011; 158:349.</a></li><li><a class="nounderline abstract_t">Singh R, Visintainer PF, Frantz ID 3rd, et al. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatol 2011; 31:176.</a></li><li><a class="nounderline abstract_t">Paul DA, Mackley A, Novitsky A, et al. Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants. Pediatrics 2011; 127:635.</a></li><li><a class="nounderline abstract_t">Mohamed A, Shah PS. Transfusion associated necrotizing enterocolitis: a meta-analysis of observational data. Pediatrics 2012; 129:529.</a></li><li><a class="nounderline abstract_t">Stritzke AI, Smyth J, Synnes A, et al. Transfusion-associated necrotising enterocolitis in neonates. Arch Dis Child Fetal Neonatal Ed 2013; 98:F10.</a></li><li><a class="nounderline abstract_t">Patel RM, Knezevic A, Shenvi N, et al. Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants. JAMA 2016; 315:889.</a></li><li><a class="nounderline abstract_t">Hay S, Zupancic JA, Flannery DD, et al. Should we believe in transfusion-associated enterocolitis? Applying a GRADE to the literature. Semin Perinatol 2017; 41:80.</a></li><li><a class="nounderline abstract_t">Kalteren WS, Bos AF, Bergman KA, et al. The short-term effects of RBC transfusions on intestinal injury in preterm infants. Pediatr Res 2023; 93:1307.</a></li><li><a class="nounderline abstract_t">Palmeira P, Quinello C, Silveira-Lessa AL, et al. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; 2012:985646.</a></li><li><a class="nounderline abstract_t">Caplan MS, Hsueh W. Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor. J Pediatr 1990; 117:S47.</a></li><li><a class="nounderline abstract_t">Caplan MS, Sun XM, Hseuh W, Hageman JR. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990; 116:960.</a></li><li><a class="nounderline abstract_t">Harris MC, Costarino AT Jr, Sullivan JS, et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 1994; 124:105.</a></li><li><a class="nounderline abstract_t">Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999; 103:766.</a></li><li><a class="nounderline abstract_t">Sharma R, Tepas JJ 3rd, Hudak ML, et al. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J Pediatr Surg 2007; 42:454.</a></li><li><a class="nounderline abstract_t">Caplan MS, MacKendrick W. Inflammatory mediators and intestinal injury. Clin Perinatol 1994; 21:235.</a></li><li><a class="nounderline abstract_t">Been JV, Lievense S, Zimmermann LJ, et al. Chorioamnionitis as a risk factor for necrotizing enterocolitis: a systematic review and meta-analysis. J Pediatr 2013; 162:236.</a></li><li><a class="nounderline abstract_t">Lee JY, Park KH, Kim A, et al. Maternal and Placental Risk Factors for Developing Necrotizing Enterocolitis in Very Preterm Infants. Pediatr Neonatol 2017; 58:57.</a></li><li><a class="nounderline abstract_t">Duci M, Frigo AC, Visentin S, et al. Maternal and placental risk factors associated with the development of necrotizing enterocolitis (NEC) and its severity. J Pediatr Surg 2019; 54:2099.</a></li><li><a class="nounderline abstract_t">MacKendrick W, Caplan M, Hsueh W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr Res 1993; 34:222.</a></li><li><a class="nounderline abstract_t">Ford H, Watkins S, Reblock K, Rowe M. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997; 32:275.</a></li><li><a class="nounderline abstract_t">Nowicki PT, Dunaway DJ, Nankervis CA, et al. Endothelin-1 in human intestine resected for necrotizing enterocolitis. J Pediatr 2005; 146:805.</a></li><li><a class="nounderline abstract_t">Nowicki PT, Caniano DA, Hammond S, et al. Endothelial nitric oxide synthase in human intestine resected for necrotizing enterocolitis. J Pediatr 2007; 150:40.</a></li><li><a class="nounderline abstract_t">Velazco CS, Fullerton BS, Hong CR, et al. Morbidity and mortality among "big" babies who develop necrotizing enterocolitis: A prospective multicenter cohort analysis. J Pediatr Surg 2017.</a></li><li><a class="nounderline abstract_t">Christensen RD, Lambert DK, Baer VL, Gordon PV. Necrotizing enterocolitis in term infants. Clin Perinatol 2013; 40:69.</a></li><li><a class="nounderline abstract_t">Lambert DK, Christensen RD, Henry E, et al. Necrotizing enterocolitis in term neonates: data from a multihospital health-care system. J Perinatol 2007; 27:437.</a></li><li><a class="nounderline abstract_t">Ng S. Necrotizing enterocolitis in the full-term neonate. J Paediatr Child Health 2001; 37:1.</a></li><li><a class="nounderline abstract_t">Bolisetty S, Lui K, Oei J, Wojtulewicz J. A regional study of underlying congenital diseases in term neonates with necrotizing enterocolitis. Acta Paediatr 2000; 89:1226.</a></li><li><a class="nounderline abstract_t">McElhinney DB, Hedrick HL, Bush DM, et al. Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. Pediatrics 2000; 106:1080.</a></li><li><a class="nounderline abstract_t">Ostlie DJ, Spilde TL, St Peter SD, et al. Necrotizing enterocolitis in full-term infants. J Pediatr Surg 2003; 38:1039.</a></li><li><a class="nounderline abstract_t">Bubberman JM, van Zoonen A, Bruggink JLM, et al. Necrotizing Enterocolitis Associated with Congenital Heart Disease: a Different Entity? J Pediatr Surg 2019; 54:1755.</a></li><li><a class="nounderline abstract_t">Spinner JA, Morris SA, Nandi D, et al. Necrotizing Enterocolitis and Associated Mortality in Neonates With Congenital Heart Disease: A Multi-Institutional Study. Pediatr Crit Care Med 2020; 21:228.</a></li></ol></div><div id="topicVersionRevision">Topic 4991 Version 57.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21247316" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2362230" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Pathology of neonatal necrotizing enterocolitis: a ten-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27866661" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : A critical question for NEC researchers: Can we create a consensus definition of NEC that facilitates research progress?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28316967" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The Role of Mucosal Immunity in the Pathogenesis of Necrotizing Enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15201403" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2194009" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Gastrointestinal host defense and necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27940091" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pathogenesis of NEC: Role of the innate and adaptive immune response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18091350" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16481238" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Mechanism of nitric oxide-mediated intestinal barrier failure: insight into the pathogenesis of necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17027734" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Necrotising enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27534694" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Necrotizing enterocolitis: new insights into pathogenesis and mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28410573" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Risk factors for necrotizing enterocolitis in neonates: a systematic review of prognostic studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29270303" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : NEC-zero recommendations from scoping review of evidence to prevent and foster timely recognition of necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25992911" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Intestinal microbiota and its relationship with necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26969089" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21258263" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22845166" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28274256" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27986328" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pathogenesis of NEC: Impact of an altered intestinal microbiome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11157169" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Molecular analysis of commensal host-microbial relationships in the intestine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20308210" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36081629" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Metabolic model of necrotizing enterocolitis in the premature newborn gut resulting from enteric dysbiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25899687" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30172430" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Early Antibiotic Exposure and Adverse Outcomes in Preterm, Very Low Birth Weight Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21489560" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24529620" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19117861" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32424744" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Association of initial empirical antibiotic therapy with increased risk of necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36179887" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Early Empirical Antibiotics and Adverse Clinical Outcomes in Infants Born Very Preterm: A Population-Based Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32553865" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Early Use of Antibiotics Is Associated with a Lower Incidence of Necrotizing Enterocolitis in Preterm, Very Low Birth Weight Infants: The NEOMUNE-NeoNutriNet Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15800406" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Feeding strategies and necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27836286" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Acylcarnitine Profiles Reflect Metabolic Vulnerability for Necrotizing Enterocolitis in Newborns Born Premature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2194014" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Intraluminal pathogenesis of necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22271701" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Incidence and timing of presentation of necrotizing enterocolitis in preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17382103" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Is EGF the Holy Grail for NEC?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29599768" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Mother's Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30173873" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Diet during Pregnancy and Infancy and the Infant Intestinal Microbiome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10692746" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Oral gastrografin in neonates: a note of caution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4080498" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : [Role of a hypertonic theophylline solution and blood transfusion in necrotizing colitis].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1174138" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Necrotizing enterocolitis in low-birth-weight infants fed an elemental formula.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16390920" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2246712" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Prevention of neonatal necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29198543" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactoferrin Counteracts This Effect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1919897" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26084844" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Clostridium butyricum Strains and Dysbiosis Linked to Necrotizing Enterocolitis in Preterm Neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26787171" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A Necrotizing Enterocolitis-Associated Gut Microbiota Is Present in the Meconium: Results of a Prospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17952466" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Necrotizing enterocolitis of the neonate with Clostridium perfringens: diagnosis, clinical course, and role of alpha toxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20589982" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31493911" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Detection of Cytomegalovirus in Intestinal Tissue of Infants with Necrotizing Enterocolitis or Spontaneous Intestinal Perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18534621" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2194008" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Intestinal ischemia and necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17272623" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Persistent diastolic flow reversal in abdominal aortic Doppler-flow profiles is associated with an increased risk of necrotizing enterocolitis in term infants with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25868405" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Serious congenital heart disease and necrotizing enterocolitis in very low birth weight neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/839341" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Necrotizing enterocolitis and hyperviscosity in the newborn infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6476115" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Effect of polycythemia on gastrointestinal blood flow and oxygenation in piglets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20051059" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Is "transfusion-associated necrotizing enterocolitis" an authentic pathogenic entity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20650470" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21067771" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4734313" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The gastrointestinal complications of neonatal umbilical venous exchange transfusion: a clinical and experimental study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2681634" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Cocaine: clinical pharmacology and toxicology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18298781" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Antenatal umbilical Doppler abnormalities: an independent risk factor for early onset neonatal necrotizing enterocolitis in premature infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21146187" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Association between red blood cell transfusions and necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21273983" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21402638" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22351894" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Transfusion associated necrotizing enterocolitis: a meta-analysis of observational data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22447991" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Transfusion-associated necrotising enterocolitis in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26934258" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27866662" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Should we believe in transfusion-associated enterocolitis? Applying a GRADE to the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35115712" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The short-term effects of RBC transfusions on intestinal injury in preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22235228" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : IgG placental transfer in healthy and pathological pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2194011" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2348301" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8283358" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10103300" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17336180" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8070224" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Inflammatory mediators and intestinal injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22920508" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Chorioamnionitis as a risk factor for necrotizing enterocolitis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27328638" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Maternal and Placental Risk Factors for Developing Necrotizing Enterocolitis in Very Preterm Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31084912" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Maternal and placental risk factors associated with the development of necrotizing enterocolitis (NEC) and its severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8233729" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9044137" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15973323" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Endothelin-1 in human intestine resected for necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17188611" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Endothelial nitric oxide synthase in human intestine resected for necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29111080" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Morbidity and mortality among "big" babies who develop necrotizing enterocolitis: A prospective multicenter cohort analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23415264" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Necrotizing enterocolitis in term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17392837" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Necrotizing enterocolitis in term neonates: data from a multihospital health-care system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11168859" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Necrotizing enterocolitis in the full-term neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11083380" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : A regional study of underlying congenital diseases in term neonates with necrotizing enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11061778" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12861534" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Necrotizing enterocolitis in full-term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30635129" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Necrotizing Enterocolitis Associated with Congenital Heart Disease: a Different Entity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31568264" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Necrotizing Enterocolitis and Associated Mortality in Neonates With Congenital Heart Disease: A Multi-Institutional Study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
